Invesco’s Cumberland Pharmaceuticals CPIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-10,500
Closed -$77K 3720
2017
Q4
$77K Sell
10,500
-40,264
-79% -$296K ﹤0.01% 3612
2017
Q3
$358K Sell
50,764
-20,590
-29% -$142K ﹤0.01% 3402
2017
Q2
$500K Buy
71,354
+1,264
+2% +$8.34K ﹤0.01% 3317
2017
Q1
$486K Sell
70,090
-3,600
-5% -$21.8K ﹤0.01% 3346
2016
Q4
$405K Sell
73,690
-2,500
-3% -$13K ﹤0.01% 3381
2016
Q3
$381K Buy
76,190
+2,000
+3% +$9.41K ﹤0.01% 3360
2016
Q2
$334K Sell
74,190
-4,000
-5% -$18.3K ﹤0.01% 3383
2016
Q1
$351K Sell
78,190
-3,450
-4% -$16.4K ﹤0.01% 3390
2015
Q4
$429K Sell
81,640
-3,050
-4% -$17.4K ﹤0.01% 3317
2015
Q3
$488K Hold
84,690
﹤0.01% 3253
2015
Q2
$606K Sell
84,690
-3,950
-4% -$27.5K ﹤0.01% 3300
2015
Q1
$591K Buy
88,640
+34,800
+65% +$217K ﹤0.01% 3276
2014
Q4
$322K Hold
53,840
﹤0.01% 3483
2014
Q3
$266K Sell
53,840
-4,400
-8% -$21.3K ﹤0.01% 3557
2014
Q2
$262K Sell
58,240
-1,300
-2% -$5.8K ﹤0.01% 3599
2014
Q1
$268K Buy
59,540
+1,120
+2% +$5.33K ﹤0.01% 3634
2013
Q4
$299K Sell
58,420
-180
-0.3% -$879 ﹤0.01% 3672
2013
Q3
$265K Sell
58,600
-35,550
-38% -$177K ﹤0.01% 3663
2013
Q2
$481K Buy
+94,150
New +$468K ﹤0.01% 3296

Other funds holding CPIX

Invesco's CPIX Position: Q1 2018 in Review

Invesco sold out of Cumberland Pharmaceuticals (CPIX) in Q1 2018, closing a stake of 10,500 shares — an estimated $77K sold.

Invesco first reported a position in CPIX in Q2 2013 and held it in 19 quarters. The position peaked at $606K in Q2 2015. 29 funds tracked by Wall St. Rank hold CPIX as of Q1 2018.

  • Invesco reported no remaining Cumberland Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
  • Invesco sold 10,500 Cumberland Pharmaceuticals shares in Q1 2018, an estimated $77K.
  • Invesco first reported a position in Cumberland Pharmaceuticals in Q2 2013 and held it in 19 quarters.
  • Invesco's Cumberland Pharmaceuticals position peaked at $606K in Q2 2015.
  • 29 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q1 2018.

Based on Invesco's 13F filing for Q1 2018, filed 15 May 2018.